If you go to any meetings on precision medicine, you’ll have noticed the increasing amount of interest in artificial intelligence (AI).
As the volume and depth of genomic data grows, bioinformaticians are translating genomic data into interpretable patterns leading to new biological insight.
“We Need to be Able to Handle Large Scale Datasets to Prepare for This ‘Big Data’ Era” – Mark Gerstein
Mark Gerstein, PhD, gives us some inside information on applying computational approaches to problems in molecular biology.
Last month, Tristan Roberts became the first human to inject himself with an untested, experimental gene therapy, live on Facebook.
If you have been keeping tabs on the website this week, then you’ll be aware at just how much of a booming year biotech companies are having.
The FDA has warned that it will be coming down hard on anyone carrying out do-it-yourself gene therapy, in a recent statement.
This Thanksgiving investors are thankful that the S&P 500 is up about 15% year to date, with that path expected to continue to the end of the year.
Josiah Zayner, the scientist who left NASA to bring genetic engineering to consumers has modified his own genome with CRISPR (true DIY style).
In an attempt to make precision medicine the next mainstream, China are leading the way with Artificial Intelligence (AI).
We caught up with patient advocate Karen Keeley ahead of Festival of Genomics London 2018.
This new whitepaper describes the key attributes of absorbance and fluorescence quantification methods, when to use each and when to use both.
The revolutionary gene-editing tool, CRISPR, will grow into a $10 billion market by 20215, according to Citi GPS’ new report.